Articles of Association for Genmab A/S
December 18, 2015 08:36 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated December 10, 2015. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel...
Genmab præsenterer ved den 34. årlige J.P. Morgan Healthcare konference
December 15, 2015 10:29 ET
|
Genmab A/S
Pressemeddelelse
København, Danmark, 15. december 2015 – Genmab A/S (Nasdaq Copenhagen: GEN) offentliggjorde i dag, at selskabets CEO, Jan van de Winkel, ph.d., vil give en præsentation om Genmab...
Genmab to Present at the 34th Annual J.P. Morgan Healthcare Conference
December 15, 2015 10:29 ET
|
Genmab A/S
Media Release
Copenhagen, Denmark; December 15, 2015 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 34th Annual...
Report Pursuant to Section 28a of the Danish Securities Trading Act
December 10, 2015 13:20 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; December 10, 2015 – In accordance with Section 28a of the Danish Securities Trading Act, the company’s board members and executives have given Genmab A/S...
Indberetning i medfør af værdipapirhandelslovens § 28a
December 10, 2015 13:20 ET
|
Genmab A/S
Selskabsmeddelelse
København, Danmark, 10. december 2015 – I henhold til værdipapirhandelslovens § 28a har virksomhedens bestyrelsesmedlemmer og direktører givet Genmab A/S (Nasdaq Copenhagen:...
Grant of Restricted Stock Units to Board Members and Management and Grant of Warrants to Management and Employees in Genmab
December 10, 2015 13:13 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; December 10, 2015 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 23,145 restricted stock units...
Tildeling af restricted stock units til bestyrelsesmedlemmer og direktion og tildeling af warrants til direktion og medarbejdere i Genmab
December 10, 2015 13:13 ET
|
Genmab A/S
Selskabsmeddelelse
København, Danmark, 10. december 2015 – Genmab A/S (Nasdaq Copenhagen: GEN) offentliggjorde i dag, at på et bestyrelsesmøde har bestyrelsen besluttet at tildele 23.145...
Genmab Achieves USD 5 Million Milestone in Daratumumab Collaboration with Janssen
December 09, 2015 09:43 ET
|
Genmab A/S
Company Announcement
Genmab to receive USD 5 million milestone payment from Janssen
Milestone triggered by progress in the Phase II study of daratumumab in non-Hodgkin’s lymphoma...
Genmab når milestone på USD 5 mio. i daratumumab-samarbejdet med Janssen
December 09, 2015 09:43 ET
|
Genmab A/S
Selskabsmeddelelse
Genmab vil modtage milestonebetaling fra Janssen på USD 5 mio.
Milestone udløst af fremskridt i fase II studiet med daratumumab til behandling af non-Hodgkins lymfom...
Genmab’s 2015 R&D Update Live from Orlando
December 08, 2015 07:20 ET
|
Genmab A/S
Media Release
2015 R&D Update held in Orlando, Florida following ASH conference today will also be webcast live
Speakers to include Key Opinion Leaders & Executive...